Long Term Follow-up Study to Assess Durability of Sustained Virologic Response in Alisporivir-treated Hepatitis C Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

723

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Hepatitis C
Interventions
DRUG

Alisporivir

Intervention of interest; follow-up after ALV-active study

Trial Locations (119)

112

Novartis Investigative Site, Taipei

600

Novartis Investigative Site, Chiayi City

640

Novartis Investigative Site, Douliu

807

Novartis Investigative Site, Kaohsiung City

1083

Novartis Investigative Site, Budapest

1097

Novartis Investigative Site, Budapest

1126

Novartis Investigative Site, Budapest

2145

Novartis Investigative Site, Westmead

2217

Novartis Investigative Site, Kogarah

2747

Novartis Investigative Site, Kingswood

3065

Novartis Investigative Site, Fitzroy

4032

Novartis Investigative Site, Debrecen

4120

Novartis Investigative Site, Greenslopes

7400

Novartis Investigative Site, Kaposvár

7624

Novartis Investigative Site, Pécs

8000

Novartis Investigative Site, Székesfehérvár

9000

Novartis Investigative Site, Ghent

10002

Novartis Investigative Site, Taipei

10126

Novartis Investigative Site, Torino

10700

Novartis Investigative Site, Bangkok

10969

Novartis Investigative Site, Berlin

14000

Novartis Investigative Site, Mexico City

20089

Novartis Investigative Site, Rozzano

20099

Novartis Investigative Site, Hamburg

20121

Novartis Investigative Site, Milan

20122

Novartis Investigative Site, Milan

20162

Novartis Investigative Site, Milan

20401

Novartis Investigative Site, Keelung

22332

Novartis Investigative Site, Incheon

24146

Novartis Investigative Site, Kiel

25123

Novartis Investigative Site, Brescia

27100

Novartis Investigative Site, Pavia

28222

Novartis Investigative Site, Majadahonda

30625

Novartis Investigative Site, Hanover

33305

Novartis Investigative Site, Linkou District

34098

Novartis Investigative Site, Fatih / Istanbul

34209

Novartis Investigative Site, Bradenton

35040

Novartis Investigative Site, Izmir

40002

Novartis Investigative Site, Khon Kaen

40138

Novartis Investigative Site, Bologna

Novartis Investigative Site, Bologna

40447

Novartis Investigative Site, Taichung

41014

Novartis Investigative Site, Seville

43100

Novartis Investigative Site, Parma

46014

Novartis Investigative Site, Valencia

46237

Novartis Investigative Site, Indianapolis

50200

Novartis Investigative Site, Chiang Mai

50937

Novartis Investigative Site, Cologne

55131

Novartis Investigative Site, Mainz

60590

Novartis Investigative Site, Frankfurt

62703

Novartis Investigative Site, Springfield

64020

Novartis Investigative Site, Monterrey

69317

Novartis Investigative Site, Lyon

75014

Novartis Investigative Site, Paris

76012

Novartis Investigative Site, Arlington

77030

Novartis Investigative Site, Houston

78215

Novartis Investigative Site, San Antonio

79106

Novartis Investigative Site, Freiburg im Breisgau

80135

Novartis Investigative Site, Napoli

83301

Novartis Investigative Site, Niaosong Township

84124

Novartis Investigative Site, Salt Lake City

90110

Novartis Investigative Site, Songkhla

90127

Novartis Investigative Site, Palermo

92037

Novartis Investigative Site, La Jolla

92101

Novartis Investigative Site, San Diego

92110

Novartis Investigative Site, Clichy

93003

Novartis Investigative Site, Ventura

94010

Novartis Investigative Site, Créteil

96814

Novartis Investigative Site, Honolulu

100000

Novartis Investigative Site, Hanoi

110070

Novartis Investigative Site, Delhi

111123

Novartis Investigative Site, Moscow

141001

Novartis Investigative Site, Ludhiana

197376

Novartis Investigative Site, Saint Petersburg

200515

Novartis Investigative Site, Craiova

400012

Novartis Investigative Site, Mumbai

500012

Novartis Investigative Site, Hyderabad

700506

Novartis Investigative Site, Iași

75246-2096

Novartis Investigative Site, Dallas

C1125ABE

Novartis Investigative Site, Buenos Aires

C1405BCK

Novartis Investigative Site, Buenos Aires

T2N 4N1

Novartis Investigative Site, Calgary

V5Z 1J4

Novartis Investigative Site, Vancouver

v6z 2k5

Novartis Investigative Site, Vancouver

M5G 2C4

Novartis Investigative Site, Torono

06202

Novartis Investigative Site, Nice

04103

Novartis Investigative Site, Leipzig

Unknown

Novartis Investigative Site, Hong Kong

Novartis Investigative Site, Iași

Novartis Investigative Site, Hanoi

Novartis Investigative Site, Ho Chi Minh City

H-5600

Novartis Investigative Site, Békéscsaba

00133

Novartis Investigative Site, Roma

00161

Novartis Investigative Site, Roma

15-540

Novartis Investigative Site, Bialystok

85-030

Novartis Investigative Site, Bydgoszcz

91-347

Novartis Investigative Site, Lódz

01-201

Novartis Investigative Site, Warsaw

42-400

Novartis Investigative Site, Zawiercie

020125

Novartis Investigative Site, Bucharest

021105

Novartis Investigative Site, Bucharest

030317

Novartis Investigative Site, Bucharest

050524

Novartis Investigative Site, Bucharest

602-739

Novartis Investigative Site, Busan

463-712

Novartis Investigative Site, Seongnam-si

626-770

Novartis Investigative Site, Yangsan

03722

Novartis Investigative Site, Seoul

602-715

Novartis Investigative Site, Busan

614-735

Novartis Investigative Site, Pusan

08003

Novartis Investigative Site, Barcelona

08035

Novartis Investigative Site, Barcelona

B15 2TT

Novartis Investigative Site, Birmingham

G12 OYN

Novartis Investigative Site, Glasgow - Scotland

E1 1BB

Novartis Investigative Site, London

SE5 9RS

Novartis Investigative Site, London

SW17 0QT

Novartis Investigative Site, London

NE7 7DN

Novartis Investigative Site, Newcastle upon Tyne

NG7 2UH

Novartis Investigative Site, Nottingham

PL6 8DH

Novartis Investigative Site, Plymouth

Sponsors
All Listed Sponsors
lead

Debiopharm International SA

INDUSTRY